OVEREXPRESSION OF THE HUMAN LYSOSOMAL-ENZYME ALPHA-L-IDURONIDASE IN CHINESE-HAMSTER OVARY CELLS

被引:82
作者
KAKKIS, ED [1 ]
MATYNIA, A [1 ]
JONAS, AJ [1 ]
NEUFELD, EF [1 ]
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA
关键词
D O I
10.1006/prep.1994.1035
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We developed a Chinese hamster ovary (CHO) cell line that produces and secretes large quantities of recombinant human alpha-L-iduronidase, the lysosomal hydrolase deficient in mucopolysaccharidosis I (Hurler, Hurler-Scheie, and Scheie syndromes). The alpha-L-iduronidase cDNA was introduced into a vector containing the cytomegalovirus immediate early gene promoter/enhancer, a murine immunoglobulin Calpha region intron, and the bovine growth hormone polyadenylation signal. Following cotransfection with a plasmid containing the neomycin resistance gene, stably transfected lines were selected with G-418. The highest expressing CHO cell line contained 1400-6000 units of alpha-L-iduronidase per milligram of protein, or 0.6-2.4% of total cell protein. Secreted alpha-L-iduronidase was 3000- to 7000 fold increased, with about 5000 units accumulating in 24 h per 10(7) cells. The activity and distribution of five other lysosomal glycosidases were not significantly affected. Metabolic labeling showed that half of the newly synthesized alpha-L-iduronidase was secreted, but generally less was recovered due to its instability in the medium. It was post-translationally processed as previously shown for alpha-L-iduronidase of human fibroblasts. Recombinant alpha-L-iduronidase was efficiently endocytosed by Hurler fibroblasts utilizing a mannose 6-phosphate-dependent mechanism (half maximal uptake at 0.7 nM) and was ''corrective'' for abnormal glycosaminoglycan accumulation (half maximal correction at 0.7 pm). The half-life of the recombinant enzyme was 5 days following uptake into Hurler fibroblasts. Production in a 5-liter microcarrier culture system permitted the collection of 15 mg or more per day. Purification to apparent homogeneity was achieved by sequential chromatography on concanavalin A-Sepharose, heparin-Sepharose, and Sephacryl S-200. Amino acid sequencing of the purified protein proved its identity, and purity. The N-terminus contained alanine 26, inconsistent with previous conclusions regarding the site of signal peptide cleavage. Sufficient purified alpha-L-iduronidase can now be produced for biochemical studies and for therapeutic attempts in animal models. (C) 1994 Academic Press, Inc.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 31 条
  • [1] CORRECTION OF HUMAN MUCOPOLYSACCHARIDOSIS TYPE-VI FIBROBLASTS WITH RECOMBINANT N-ACETYLGALACTOSAMINE-4-SULFATASE
    ANSON, DS
    TAYLOR, JA
    BIELICKI, J
    HARPER, GS
    PETERS, C
    GIBSON, GJ
    HOPWOOD, JJ
    [J]. BIOCHEMICAL JOURNAL, 1992, 284 : 789 - 794
  • [2] CORRECTION OF MUCOPOLYSACCHARIDOSIS TYPE-I FIBROBLASTS BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ALPHA-L-IDURONIDASE GENE
    ANSON, DS
    BIELICKI, J
    HOPWOOD, JJ
    [J]. HUMAN GENE THERAPY, 1992, 3 (04) : 371 - 379
  • [3] REPLACEMENT THERAPY FOR INHERITED ENZYME DEFICIENCY - MACROPHAGE-TARGETED GLUCOCEREBROSIDASE FOR GAUCHERS-DISEASE
    BARTON, NW
    BRADY, RO
    DAMBROSIA, JM
    DIBISCEGLIE, AM
    DOPPELT, SH
    HILL, SC
    MANKIN, HJ
    MURRAY, GJ
    PARKER, RI
    ARGOFF, CE
    GREWAL, RP
    YU, KT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) : 1464 - 1470
  • [4] BARTON RW, 1971, J BIOL CHEM, V246, P7773
  • [5] RECOMBINANT HUMAN IDURONATE-2-SULFATASE - CORRECTION OF MUCOPOLYSACCHARIDOSIS-TYPE-II FIBROBLASTS AND CHARACTERIZATION OF THE PURIFIED ENZYME
    BIELICKI, J
    HOPWOOD, JJ
    WILSON, PJ
    ANSON, DS
    [J]. BIOCHEMICAL JOURNAL, 1993, 289 : 241 - 246
  • [6] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [7] HUMAN ALPHA-L-IDURONIDASE .1. PURIFICATION, MONOCLONAL-ANTIBODY PRODUCTION, NATIVE AND SUBUNIT MOLECULAR MASS
    CLEMENTS, PR
    BROOKS, DA
    SACCONE, GTP
    HOPWOOD, JJ
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (01): : 21 - 28
  • [8] GLASER JH, 1973, J LAB CLIN MED, V82, P969
  • [9] NEW TECHNIQUE FOR ASSAY OF INFECTIVITY OF HUMAN ADENOVIRUS 5 DNA
    GRAHAM, FL
    VANDEREB, AJ
    [J]. VIROLOGY, 1973, 52 (02) : 456 - 467
  • [10] Hall C W, 1978, Methods Enzymol, V50, P439